Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Type 1 diabetes
2023 Standout
Works of Berrin Ergun-Longmire being referenced
Growth Hormone Treatment and Risk of Second Neoplasms in the Childhood Cancer Survivor
2006
Oral Insulin Therapy to Prevent Progression of Immune‐Mediated (Type 1) Diabetes
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Berrin Ergun-Longmire | 148 | 62 | 196 | 126 | 17 | 378 | |
| Angelo Acquafredda | 98 | 63 | 106 | 99 | 28 | 368 | |
| Sylvie Tenoutasse | 136 | 106 | 169 | 60 | 26 | 349 | |
| Hanna Liisa Lenko | 149 | 47 | 66 | 132 | 17 | 385 | |
| Paul Mahoney | 42 | 80 | 125 | 58 | 11 | 423 | |
| Hílton Kuperman | 146 | 42 | 244 | 145 | 27 | 361 | |
| W W Cleveland | 92 | 59 | 126 | 93 | 18 | 374 | |
| J. A. Batch | 191 | 60 | 161 | 179 | 16 | 439 | |
| John Wurzel | 68 | 74 | 63 | 142 | 21 | 350 | |
| Nadine Lucidarme | 83 | 72 | 138 | 75 | 13 | 359 | |
| Attila Tar | 235 | 33 | 127 | 220 | 22 | 417 |
All Works
Login with ORCID to disown or claim papers
Loading papers...